NS-136 treatment study for schizophrenia relapse
Treatments studied
Part of Mental health clinical trials.
This study tests whether NS-136, a new medication, can help people with schizophrenia who are experiencing a relapse or worsening of symptoms. The study measures how well the medication works and what side effects it causes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 with a healthy body weight (BMI 18–34)
- Diagnosed with schizophrenia (not schizoaffective disorder or first-episode psychosis)
- Currently experiencing a relapse or acute worsening of psychotic symptoms
- Moderate-to-severe symptom severity and willing to stop all other antipsychotic medications during the study
- No significant heart disease, uncontrolled diabetes, seizure history, or active suicidal thoughts with a plan
- Not pregnant (if able to become pregnant) and willing to use contraception for 3 months after last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, NBI-1117568, to see if it can help prevent a relapse of schizophrenia symptoms. It is for adults who have been stable on other antipsychotics and want to avoid returning to the hospital for a psychiatric stay.
This trial tests an investigational medicine called NBI-1117568 in adults with schizophrenia who are currently having a relapse or worsening of symptoms and need to stay in the hospital. The goal is to see if the medicine is safe and effective.
This study tests an experimental drug (NBI-1117568) for people with schizophrenia who are currently in the hospital due to worsening symptoms. Participants stop their current antipsychotic and take the study drug to see if it can help control symptoms.
This study tests a new medicine called NBI-1117568 for adults with schizophrenia over a longer period of time. Participants will stop their current antipsychotics and take this new drug to see how well it works and how safe it is.
This study tests a new medication called NS-136 for the first time in people. It aims to see how safe and tolerable the drug is when given to healthy adults. If you are generally healthy, you may be able to take part and help researchers learn about this potential new treatment.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
Hear when a new Schizophrenia(Acute) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.